WHAT IS THE VALUE OF BIOMARKERS FOR DRUG DEVELOPMENT IN OSTEOARTHRITIS?
- Author(s):
- Lotz, M.; Martel-Pelletier, J.; Christiansen, C.; Berenbaum, F.; Brandi, M.L.; Bruyere, O.; Chapurlat, R.; Colette, J.; Cooper, C.; Heinegard, D.; Kanis, J.A.; Kraus, V.; Laslop, A.; Lems, W.; Lohmander, S.; Meulenbelt, I. (0000-0001-7786-7081); Pelletier, J.P.; Raynauld, J.P.; Reiter, S.; Rizzoli, R.; Sandel, L.; Spector, T.; Spil, W.E. van; Reginster, J.Y.
- Published
- 2013
- Publication type
- Article / Letter to editor
- Date issued
- 2013-04-30
- Language
- English
- Is part of
- Osteoporosis International (2013), Vol. 24, p. S77-S78
- hdl
- 1887/100758